One paper reported that the penetrance of diabetes in pathogenic HNF1A/HNF4A variant carriers was much lower in carriers identified through unselected cohorts (32%) vs cohorts of individuals with a molecular diagnosis (98%).35 However, there was no difference in diabetes penetrance between different ascertainment contexts for carriers of pathogenic GCK variants. The gene discussed is GCK; the disease is diabetes mellitus.